Evidence map›Paper›PMID 28816243›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Anne S Berry, Vyoma D Shah, Daniella J Furman, Robert L White, Suzanne L Baker, James P O'Neil, Mustafa Janabi, Mark D'Esposito, William J Jagust

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Methylphenidate undermines or enhances divergent creativity depending on baseline dopamine synthesis capacity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  3. Trial
  4. Article
  5. Dopaminergic mechanisms supporting hippocampal postencoding dynamics in humans.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Review
  7. Article
  8. A dopaminergic basis of behavioral control.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  17. Article
  18. Functional dynamics of dopamine synthesis during monetary reward and punishment processing.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Anne S BerryLawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID 0000-0002-5086-3643
Vyoma D ShahLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Daniella J FurmanHelen Wills Neuroscience Institute, University of California Berkeley, Berkeley, CA USA.
Robert L WhiteHelen Wills Neuroscience Institute, University of California Berkeley, Berkeley, CA USA.
Suzanne L BakerLawrence Berkeley National Laboratory, Berkeley, CA, USA.
James P O'NeilLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Mustafa JanabiLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Mark D'EspositoHelen Wills Neuroscience Institute, University of California Berkeley, Berkeley, CA USA.
William J JagustLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Lawrence Berkeley National Laboratory · USUniversity of California, Berkeley · US

Funding

Aging Brain, Cognition, and DopamineR01AG044292 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI JAGUST, WILLIAM J. · 2013 to 2017
$3.6M
Dopamine and Frontostriatal FunctionR01DA034685 · NIDA · UNIVERSITY OF CALIFORNIA BERKELEY · PI D'ESPOSITO, MARK · 2013 to 2017
$3.4M
Aversive motivation and cognitive controlF32DA038927 · NIDA · UNIVERSITY OF CALIFORNIA BERKELEY · PI FURMAN, DANIELLA JULIA · 2015 to 2018
$171k
Dopaminergic modulation of networks mediating cognitive flexibility in older adulF32AG047686 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BERRY, ANNE SHIVELY · 2014 to 2016
$158k
NIA NIH HHS F32 AG047686NIA NIH HHS R01 AG044292NIDA NIH HHS F32 DA038927NIDA NIH HHS R01 DA034685
6 · The paper itself

Abstract

Positron Emission Tomography (PET) imaging allows the estimation of multiple aspects of dopamine function including dopamine synthesis capacity, dopamine release, and D2/3 receptor binding. Though dopaminergic dysregulation characterizes a number of neuropsychiatric disorders including schizophrenia and addiction, there has been relatively little investigation into the nature of relationships across dopamine markers within healthy individuals. Here we used PET imaging in 40 healthy adults to compare, within individuals, the estimates of dopamine synthesis capacity (K

Indexed as

AdolescentAdultAromatic-L-Amino-Acid DecarboxylasesBrain MappingCorpus StriatumDopamineDopamine AntagonistsDopamine Uptake InhibitorsFemaleHumansMaleMethylphenidatePositron-Emission TomographyProtein BindingRacloprideRadiopharmaceuticalsAromatic-L-Amino-Acid DecarboxylasesDopamineDopamine AntagonistsDopamine Uptake InhibitorsDRD2 protein, humanDRD3 protein, humanMethylphenidateRacloprideRadiopharmaceuticalsReceptors, Dopamine D2Receptors, Dopamine D3

Identifiers

PMID28816243
PMCPMC5916345
OpenAlexW2748692383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.